KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Cash & Equivalents (2016 - 2025)

LifeMD filings provide 14 years of Cash & Equivalents readings, the most recent being $36.8 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 12.66% to $36.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $36.8 million, a 12.66% increase, with the full-year FY2025 number at $36.8 million, up 12.66% from a year prior.
  • Cash & Equivalents hit $36.8 million in Q4 2025 for LifeMD, up from $23.8 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $41.3 million in Q4 2021 to a low of $4.0 million in Q4 2022.
  • Median Cash & Equivalents over the past 5 years was $24.4 million (2022), compared with a mean of $23.6 million.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 5080.48% in 2021 and later crashed 90.42% in 2022.
  • LifeMD's Cash & Equivalents stood at $41.3 million in 2021, then crashed by 90.42% to $4.0 million in 2022, then skyrocketed by 737.26% to $33.1 million in 2023, then dropped by 1.49% to $32.7 million in 2024, then grew by 12.66% to $36.8 million in 2025.
  • The last three reported values for Cash & Equivalents were $36.8 million (Q4 2025), $23.8 million (Q3 2025), and $36.2 million (Q2 2025) per Business Quant data.